Redcare Pharmacy N.V. / NL0012044747
10.11.2025 - 18:31:23Change in Redcare Pharmacy’s Managing Board: New CFO Hendrik Krampe.
| EQS-Ad-hoc: Redcare Pharmacy N.V. / Key word(s): Personnel 10-Nov-2025 / 18:31 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group. The issuer is solely responsible for the content of this announcement. Change in Redcare Pharmacy’s Managing Board: New CFO Hendrik Krampe. Sevenum, the Netherlands, 10 November 2025. Redcare Pharmacy announces today that the Supervisory Board has designated Hendrik Krampe as member of the Managing Board and Chief Financial Officer (CFO), effective 1 December 2025. The appointment of Hendrik Krampe is on the agenda of the Annual General Meeting to be held in April 2026 for consultation. Contact: rikutis consulting Thomas Schnorrenberg Cel: +49 151 46 53 13 17 E-Mail: presse@shop-apotheke.com End of Inside Information 10-Nov-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. View original content: EQS News |
| Language: | English |
| Company: | Redcare Pharmacy N.V. |
| Erik de Rodeweg 11-13 | |
| 5975 WD Sevenum | |
| Netherlands | |
| Phone: | 0800 - 200 800 300 |
| Fax: | 0800 - 90 70 90 20 |
| E-mail: | investors@redcare-pharmacy.com |
| Internet: | www.redcare-pharmacy.com |
| ISIN: | NL0012044747, DE000A19Y072 |
| WKN: | A2AR94, A19Y072 |
| Indices: | MDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 2227214 |
| End of Announcement | EQS News Service |
| |
2227214 10-Nov-2025 CET/CEST
